Fig. 1From: Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatmentExomiRNAs and the diagnosis of hematologic neoplasms. After the blood is obtained from the subject, it can be used for detection. The microfluidic approach is one the most accurate ways of detection (demonstrated in the figure as a microfluidic chip). These malignancies have their specific miRNA as the tumor marker. Here four disorders (AML: Acute myeloid leukemia, CML: Chronic myeloid leukemia, CLL: Chronic lymphocytic leukemia, and MM: Multiple myeloma) have been illustratedBack to article page